Startseite UR
![]() | Eine Stufe nach oben |
, Lacabaratz, Christine, Ellefsen-Lavoie, Kim, Stöhr, Wolfgang, Lelièvre, Jean-Daniel, Bart, Pierre-Alexandre, Launay, Odile, Weber, Jonathan, Salzberger, Bernd, Wiedemann, Aurélie, Surenaud, Mathieu, Koelle, David M., Wolf, Hans, Wagner, Ralf, Rieux, Véronique, Montefiori, David C., Yates, Nicole L., Tomaras, Georgia D., Gottardo, Raphael, Mayer, Bryan, Ding, Song, Thiébaut, Rodolphe, McCormack, Sheena, Chêne, Geneviève und Pantaleo, Giuseppe
(2020)
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial.
PLOS Pathogens 16 (6), e1008522.
Volltext nicht vorhanden.
und Corey, Lawrence
(2019)
Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial.
The Lancet HIV 6 (11), e737-e749.
Volltext nicht vorhanden.
, Harari, Alexandre
, Hall, Olivia, Martin, Ricardo, Maillard, Michel, Dorta, Gian, Bart, Pierre-Alexandre, Kremer, Eric J.
, Tartaglia, Jim, Wagner, Ralf, Esteban, Mariano, Levy, Yves und Pantaleo, Giuseppe
(2011)
DNA/NYVAC Vaccine Regimen Induces HIV-Specific CD4 and CD8 T-Cell Responses in Intestinal Mucosa.
Journal of Virology 85 (19), S. 9854-9862.
Volltext nicht vorhanden.
, Wolf, Hans, Frachette, Marie-Joelle, Bieler, Kurt, Sheppard, Neil, Harari, Alexandre
, Bart, Pierre-Alexandre, Liljeström, Peter
, Wagner, Ralf, Pantaleo, Giuseppe und Heeney, Jonathan L.
(2009)
Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens.
Journal of Virology 83 (11), S. 5881-5889.
Volltext nicht vorhanden.
, Bart, Pierre-Alexandre, Stöhr, Wolfgang, Tapia, Gonzalo, Garcia, Miguel, Medjitna-Rais, Emmanuelle, Burnet, Séverine, Cellerai, Cristina, Erlwein, Otto, Barber, Tristan, Moog, Christiane
, Liljestrom, Peter
, Wagner, Ralf, Wolf, Hans, Kraehenbuhl, Jean-Pierre, Esteban, Mariano, Heeney, Jonathan
, Frachette, Marie-Joelle, Tartaglia, James, McCormack, Sheena, Babiker, Abdel, Weber, Jonathan und Pantaleo, Giuseppe
(2008)
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.
The Journal of Experimental Medicine 205 (1), S. 63-77.
Volltext nicht vorhanden.
, Barber, Tristan, Harari, Alexandre
, Guimaraes-Walker, Ana, Khonkarly, Mona, Sheppard, Neil C., Bangala, Yolanda, Frachette, Marie-Joelle, Wagner, Ralf, Liljeström, Peter
, Kraehenbuhl, Jean-Pierre, Girard, Marc, Goudsmit, Jaap, Esteban, Mariano, Heeney, Jonathan
, Sattentau, Quentin, McCormack, Sheena, Babiker, Abdel, Pantaleo, Giuseppe und Weber, Jonathan
(2008)
EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.
Vaccine 26 (25), S. 3153-3161.
Volltext nicht vorhanden.
, Moog, Christiane
, Ciuffreda, Donatella, Cellerai, Cristina, Cowen, Miranda, Gamboni, Romilda, Burnet, Séverine, Legg, Ken, Brodnicki, Elizabeth, Wolf, Hans, Wagner, Ralf, Heeney, Jonathan
, Frachette, Marie-Joëlle, Tartaglia, Jim, Babiker, Abdel, Pantaleo, Giuseppe und Weber, Jonathan
(2008)
EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone.
Vaccine 26 (25), S. 3162-3174.
Volltext nicht vorhanden.
Publikationsserver
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707